Covid-19 genomics bulletin
COVID-19 Genomics Bulletin
19 February 2025
This report describes the epidemiology of SARS-CoV-2 (the virus that causes COVID-19) variants in Northern Ireland.
The availability of SARS-CoV-2 sequencing results is affected the current COVID-19 testing policy and practice. We continue to monitor the circulating lineages detected through clinical testing and community sentinel surveillance for changes in prevalence of genomic variants and emergence of novel variants. We use intelligence from UKHSA and other public health authorities to monitor prevalence of mutations that may be associated with changes in immunity or severity.
It should be noted that date ranges in this report are different from those reported in the Respiratory Surveillance Report, available here.
Grouping of lineages into their parent lineages is subject to change, as variant definitions and lineages under monitoring are revised.
1 Summary
-
In the 8 epidemiological weeks (09 December 2024 to 30 January 2025), 78 COVID-19 samples were sequenced in Northern Ireland.
-
The current most common SARS-CoV-2 variant in Northern Ireland is XEC (V-23DEC-01), with 18 sequenced samples, or 100% of all sequenced samples (100% of those with a lineage assigned) in the week commencing 23 December 2024.
-
More information about prevalence and growth rates of SARS-CoV-2 lineages circulating in the UK can be found in UKHSA reports published here.
2 Current Variant View - last 8 weeks
This section summarises the SARS-CoV-2 sequencing data for Northern Ireland for the last 8 weeks of sequencing data available (09 December 2024 to 30 January 2025).
In the last 8 weeks of sequencing data, the following parent lineages have been detected: XEC, KP.3, XEC.2, JN.1, KP, XEC.4, and XEC.5. The number of sequenced samples can be seen in Table 2.1 and Figure 2.1, and the numbers as a percentage of total sequenced samples are shown in Figure 2.2. The age group distribution by parent lineage is shown in Figure 2.3.
Please note that numbers of sequenced samples per week may change retrospectively due to the delay in sequencing.
Recombinant refers to any lineage starting with “X” that does not fall under any other parent lineage definition.
Table 2.1. Number (Percentage) of sequenced samples for variants in Northern Ireland over the last 8 epidemiological weeks (week commencing) |
||||||||
---|---|---|---|---|---|---|---|---|
Variant (parent lineage) |
2024-12-09 |
2024-12-16 |
2024-12-23 |
2024-12-30 |
2025-01-06 |
2025-01-13 |
2025-01-20 |
2025-01-27 |
Unassigned (Unassigned) |
2 (15.4%) |
2 (11.8%) |
0 (0) |
0 (0) |
0 (0) |
1 (25%) |
0 (0) |
0 (0) |
V-23DEC-01 (JN.1) |
2 (15.4%) |
2 (11.8%) |
1 (5.6%) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
2 (50%) |
V-23DEC-01 (KP.3) |
1 (7.7%) |
2 (11.8%) |
7 (38.9%) |
4 (44.4%) |
1 (14.3%) |
0 (0) |
2 (33.3%) |
2 (50%) |
V-23DEC-01 (XEC) |
7 (53.8%) |
7 (41.2%) |
9 (50%) |
2 (22.2%) |
4 (57.1%) |
1 (25%) |
0 (0) |
0 (0) |
V-23DEC-01 (XEC.2) |
1 (7.7%) |
2 (11.8%) |
0 (0) |
2 (22.2%) |
1 (14.3%) |
0 (0) |
2 (33.3%) |
0 (0) |
V-23DEC-01 (KP) |
0 (0) |
1 (5.9%) |
1 (5.6%) |
1 (11.1%) |
0 (0) |
0 (0) |
1 (16.7%) |
0 (0) |
V-23DEC-01 (XEC.5) |
0 (0) |
1 (5.9%) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
1 (16.7%) |
0 (0) |
V-23DEC-01 (XEC.4) |
0 (0) |
0 (0) |
0 (0) |
0 (0) |
1 (14.3%) |
2 (50%) |
0 (0) |
0 (0) |
Week Total |
13 |
17 |
18 |
9 |
7 |
4 |
6 |
4 |
Figure 2.1: Sequenced COVID-19 cases in Northern Ireland, by parent lineage and day, for the last 8 weeks of sequencing data
Figure 2.2: Percentage of sequenced COVID-19 cases in Northern Ireland, by variant and epidemiological week, for the last 8 weeks of sequencing data
Figure 2.3: Total number of sequenced COVID-19 samples in Northern Ireland by age group, faceted by parent lineage over the last 8 weeks of sequencing data
This chart only shows counts for lineages with at least 5 sequenced samples in a given age group.
Age band information is not available for all sequences, so age band distributions should be interpreted with caution.
3 Variant View - last 12 months
This section summarises the COVID-19 sequencing data for Northern Ireland over the past 12 months (28 January 2024 to 30 January 2025).
The number of sequenced samples over the past 12 months can be seen in Figure 3.1 and supplementary Table 6.2, and the numbers as a percentage of total sequenced samples are shown in Figure 3.2. The age-sex distribution by parent lineages is shown in Figure 3.3.
Figure 3.1: Sequenced COVID-19 cases in Northern Ireland, by variant and epidemiological week for the last 12 months
Figure 3.2: Percentage of sequenced COVID-19 samples in Northern Ireland by epidemiological week for the last 12 months
Figure 3.3: Total number of sequenced COVID-19 samples in Northern Ireland by age group and sex, by parent lineage over the last 12 months
This chart only shows counts for lineages with at least 5 sequenced samples in a given age group.
4 Percentage of Specimens Sequenced
Not all PCR samples are sequenced; sequencing can only be carried out on samples that have a sufficiently high viral load, which is largely determined by when the sample is taken during the course of the infection. Other factors affecting how many samples are sequenced include volume of sample available, sample quality, and sequencing laboratory capacity.
The number of COVID-19 positive PCR samples (sequenced and not sequenced) in Northern Ireland over the past 12 months (22 January 2024 to 27 January 2025) is shown in Figure 4.1. The percentage of COVID-19 positive PCR samples that have been sequenced in on a weekly basis over the past 12 months is shown in Figure 4.2, with 13.79% sequenced (4 week rolling average of 15.17%) in the week commencing 27 January 2025.
Figure 4.1: Count of sequenced and not sequenced positive COVID-19 PCR samples in Northern Ireland over the last 12 months
Figure 4.2: Percentage of positive COVID-19 samples sequenced in Northern Ireland over the last 12 months
5 Key Definitions and Interpretation
5.1 Definitions
-
Variant nomenclature - UKHSA made changes to the variant classification system from the 1st April 2022, resulting in previously assigned Variants Under Investigation (VUIs) or Variants of Concern (VOCs) to be assigned with the V nomenclature. Details of the change to the classification system can be found in Technical briefing 39 here.
-
Lineage assignment algorithm - on 29th November 2022, the lineage assignment algorithm was switched from PangoLEARN to UShER for lineage counts. PangoLEARN uses a machine learning algorithm, whereas UShER uses phylogenetic placement and produces few unassigned lineages.
5.2 Interpretation of variant data
-
Lineage counts for recent weeks may increase due to the time lag associated with whole genome sequencing.
-
Lineage calls are subject to change following analysis of genomic sequence results, which may result in fluctuations in lineage/variant counts.
6 Appendix
6.1 Total counts by lineage for the last 8 weeks of sequencing data (09 December 2024 to 30 January 2025)
Table 6.1. Summary of variants sequenced in Northern Ireland over the past 8 weeks |
|||
---|---|---|---|
Lineage |
Parent Lineage |
Variant |
Sequenced count |
KP.3.1.1 |
KP.3 |
V-23DEC-01 |
6 |
LB.1.2.2 |
JN.1 |
V-23DEC-01 |
4 |
LF.7.3 |
JN.1 |
V-23DEC-01 |
1 |
LP.8.1 |
KP |
V-23DEC-01 |
3 |
LP.8.1.1 |
KP |
V-23DEC-01 |
1 |
MC.1 |
KP.3 |
V-23DEC-01 |
12 |
MC.24 |
KP.3 |
V-23DEC-01 |
1 |
MV.1 |
JN.1 |
V-23DEC-01 |
1 |
NF.1 |
JN.1 |
V-23DEC-01 |
1 |
Unassigned |
Unassigned |
Unassigned |
5 |
XEC |
XEC |
V-23DEC-01 |
26 |
XEC.1 |
XEC |
V-23DEC-01 |
3 |
XEC.15 |
XEC |
V-23DEC-01 |
1 |
XEC.2 |
XEC.2 |
V-23DEC-01 |
6 |
XEC.2.2 |
XEC.2 |
V-23DEC-01 |
2 |
XEC.4 |
XEC.4 |
V-23DEC-01 |
3 |
XEC.5 |
XEC.5 |
V-23DEC-01 |
2 |
Total |
- |
- |
78 |
6.2 Total counts and percentage sequenced by parent lineage for the last 12 months of sequencing data (28 January 2024 to 30 January 2025)
Table 6.2. Summary of variants sequenced in Northern Ireland over the past 12 months |
||||
---|---|---|---|---|
Parent Lineage |
Variant |
WHO variant name |
Sequence count |
Percentage sequenced |
KP.3 |
V-23DEC-01 |
Omicron |
588 |
42.6 |
Unassigned |
Unassigned |
|
280 |
20.3 |
JN.1 |
V-23DEC-01 |
Omicron |
217 |
15.7 |
XEC |
V-23DEC-01 |
Omicron |
138 |
10.0 |
KP |
V-23DEC-01 |
Omicron |
74 |
5.4 |
BA.3 |
VOC-21NOV-01 |
Omicron |
31 |
2.2 |
BA.2 |
VOC-22JAN-01 |
Omicron |
19 |
1.4 |
XEC.2 |
V-23DEC-01 |
Omicron |
19 |
1.4 |
XEC.4 |
V-23DEC-01 |
Omicron |
4 |
0.3 |
XBB |
V-22OCT-02 |
Recombinant |
3 |
0.2 |
BA.2.86 |
V-23AUG-01 |
Omicron |
2 |
0.1 |
XEC.5 |
V-23DEC-01 |
Omicron |
2 |
0.1 |
EG.5.1 |
V-23JUL-01 |
Recombinant |
1 |
0.1 |
XBB.1.5 |
V-23JAN-01 |
Recombinant |
1 |
0.1 |
XEC.8 |
V-23DEC-01 |
Omicron |
1 |
0.1 |